Study of NWRD09 for persistent HPV 16 infection in women
Part of Infections clinical trials.
This trial tests an experimental treatment called NWRD09 for women who have had a persistent HPV 16 infection for at least 12 months. The goal is to see if it can clear the virus and prevent cervical changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 45 and 65 years old.
- You have had a positive test for HPV 16 for at least 12 months.
- You have had a satisfactory colposcopy exam (a special magnified view of the cervix).
- You are not pregnant, breastfeeding, or planning to become pregnant during the study, and you agree to use effective birth control if needed.
- Your blood tests show adequate organ function (checked by study doctor).
- You do not have a history of high-grade cervical abnormalities, cancer, autoimmune disease, or use of immunosuppressant medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called NWRD09 in women with high-grade cervical lesions caused by HPV16. The goal is to see if it can help eliminate the abnormal cells and reduce the risk of cervical cancer.
This trial tests a new drug called NWRD09 for women with high-grade cervical cell changes (CIN 2/3) caused by HPV type 16. The goal is to see if the drug can help clear these abnormal cells without needing surgery.
This trial tests a new drug (NWRD09) for people who have had HPV type 16 infection in the anal area for over a year. It aims to see if the drug can help clear the virus without causing serious side effects.
This study tests a new treatment (NWRD08) for women with high-grade cervical changes (CIN 2/3) caused by HPV types 16 or 18. It aims to see if the treatment can help clear the abnormal cells and prevent them from becoming cancer.
This trial tests an experimental drug called NWRD09 for women with long-lasting HPV type 16 infection that hasn't gone away. The goal is to see if it can help clear the virus and prevent precancerous changes from becoming cancer.
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
Hear when a new Persistent Cervical HPV16 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.